PRIME Education at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
PRIME Education takes part in 2 sessions at ASH 2026 in New Orleans. Its presence centres on applying new evidence in lymphoma care, with bispecific antibodies for diffuse large B-cell and follicular lymphoma and CAR T across non-Hodgkin lymphoma.
| Organization | ASH 2026 Attendance |
|---|---|
Accredited continuing medical education company producing programs for oncology and hematology care teams. | Symposium Fri Dec 11 11:00am–2:00pm Bispecific Antibodies in Action: Applying Evidence Across the DLBCL and FL Care Continuum Bispecific antibodies in relapsed diffuse large B-cell and follicular lymphoma, from sequencing with CAR-T to outpatient step-up dosing and side effects. Symposium Fri Dec 11 3:00pm–6:00pm Evidence at Every Step: Applying the Latest CAR T-Cell Data Across the NHL Care Continuum Getting relapsed lymphoma patients to CAR-T sooner, with earlier referral, bridging therapy, sequencing choices, and management of immune and nerve toxicities. |
Find decision makers at PRIME Education
Tell us what you sell and we’ll find the people at PRIME Education most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction